AIM ImmunoTech Income Statement (2010-2024) | AIM

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2010	Sep2010	Dec2010	Mar2011	Jun2011	Sep2011	Dec2011	Mar2012	Jun2012	Sep2012	Dec2012	Mar2013	Jun2013	Sep2013	Dec2013	Sep2014	Dec2018	Dec2019	Mar2020	Jun2020	Sep2020	Sep2023	Dec2023	Dec2024
Revenue & cost
Revenue	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B		0.00B	0.00B	0.00B	0.00B	0.00B
Cost of Revenue	0.00B				0.00B											0.00B	-0.00B		0.00B	0.00B	0.00B	0.00B	0.00B
Gross Profit	-0.00B				-0.00B											-0.00B	0.00B		-0.00B	-0.00B	-0.00B	0.00B	0.00B
Operating items
Research & Development	0.00B				0.00B											0.00B	-0.00B		0.00B	0.00B	0.00B	0.00B	0.00B
Selling, General & Administrative	0.00B				0.00B											0.00B	-0.00B		0.00B	0.00B	0.00B	0.01B	0.01B
Other Operating Expenses	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B		0.00B	0.00B	0.00B	0.00B	0.00B
Operating Expenses	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B		0.00B	0.00B	0.00B	0.01B	0.01B
Operating Income	-0.00B				-0.00B											-0.00B	0.00B		-0.00B	-0.00B	-0.00B	-0.01B	-0.01B
EBIT	-0.00B				-0.00B											-0.00B	0.00B		-0.00B	-0.00B	-0.00B	-0.01B	-0.01B
Non-operating items
Non Operating Investment Income																-0.00B						-0.00B	0.00B
Interest & Investment Income																					0.00B
Other Non Operating Income	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B							0.00B	0.00B
Non Operating Income	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B				0.00B	0.00B		0.00B	0.00B
Net income details
EBT	-0.00B				-0.00B											-0.00B	0.00B		-0.00B	-0.00B	-0.00B	-0.01B	-0.01B
Profit After Tax	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.01B	-0.01B	-0.00B	-0.00B	-0.01B	-0.00B	-0.00B	0.00B		-0.00B	-0.00B	-0.00B	-0.01B	-0.01B
Income from Continuing Operations	-0.00B				-0.00B											-0.00B	0.00B		-0.00B	-0.00B	-0.00B	-0.01B	-0.01B
Consolidated Net Income	-0.00B				-0.00B											-0.00B	0.00B		-0.00B	-0.00B	-0.00B	-0.01B	-0.01B
Income towards Parent Company	-0.00B				-0.00B											-0.00B	0.00B		-0.00B	-0.00B	-0.00B	-0.01B	-0.01B
Net Income towards Common Stockholders	-0.00B				-0.00B											-0.00B	0.00B		-0.00B	-0.00B	-0.00B	-0.01B	-0.01B
Additional items
EPS (Basic)	-0.01	-0.02	-0.02	-0.01	-0.02	-0.02	-0.02	-0.02	-0.02	-0.05	-0.03	-0.02	-0.03	-0.03	-0.02	-0.02	-9.70		-0.22	-0.11	-0.08	-0.17	-0.26
EPS (Weighted Average and Diluted)																						-0.17	-0.26
Shares Outstanding (Weighted Average)	0.13B				0.14B											0.19B	0.00B	0.00B	0.02B	0.04B	38.91B	0.05B	0.05B	0.06B
Shares Outstanding (Diluted Average)																						0.05B	0.05B	0.06B
EBITDA	-0.00B				-0.00B											-0.00B	0.00B		-0.00B	-0.00B	-0.00B	-0.01B	-0.01B
Interest Expenses																			0.00B	0.00B	0.00B

Research Tools

AIM ImmunoTech Income Statement (2010-2024) | AIM

Create an account

Sign In

Reset Password